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The receptor kinase BRI1 (BRASSINOSTEROID-INSEN-
SITIVE 1) is a key component in BR (brassinosteroid) perception
and signal transduction, and has a broad impact on plant
growth and development. In the present study, we demonstrate
that Arabidopsis CaM (calmodulin) binds to the recombinant
cytoplasmic domain of BRI1 in a Ca
2+-dependent manner
in vitro. In silico analysis predicted binding to Helix E of
the BRI1 kinase subdomain VIa and a synthetic peptide based
on this sequence interacted with Ca
2+/CaM. Co-expression of
CaM with the cytoplasmic domain of BRI1 in Escherichia coli
strongly reduced autophosphorylation of BRI1, in particular
on tyrosine residues, and also reduced the BRI1-mediated
transphosphorylationofE.coliproteinsontyrosine,threonineand
presumably serine residues. Several isoforms of CaM and CMLs
(CaM-like proteins) were more effective (AtCaM6, AtCaM7
and AtCML8, where At is Arabidopsis thaliana)t h a no t h e r s
(AtCaM2,AtCaM4andAtCML11)whenco-expressedwithBRI1
in E. coli. These results establish a novel assay for recombinant
BRI1 transphosphorylation activity and collectively uncover a
possible new link between Ca
2+ and BR signalling.
Key words: brassinosteroid, BRASSINOSTEROID-INSEN-
SITIVE1receptorkinase,calciumsignalling,signaltransduction,
transphosphorylation, tyrosine autophosphorylation.
INTRODUCTION
Plants contain a large family of RLKs (receptor-like kinases)
that regulate various growth and developmental processes,
phytohormone perception, and biotic and abiotic stress responses
[1–3].BRs(brassinosteroids)areessentialplantsteroidhormones
that regulate multiple aspects of plant growth and development
throughacomplexsignaltransductionpathway[4].BRsignalling
is mediated by the BR receptor, BRI1 (BRASSINOSTEROID-
INSENSITIVE 1) [5], and its co-receptor BAK1 (BRI1-
ASSOCIATED KINASE 1) [6], both of which belong to the LRR
(leucine-rich repeat) RLK family [7]. These plant RLKs contain
an LRR extracellular domain, a single-pass transmembrane do-
main and a cytoplasmic domain that consists of a protein kinase
domain ﬂanked by a juxtamembrane and a C-terminal domain.
BR signal transduction is initiated by the perception of the
hormone in the extracellular domain of the BRI1 receptor kinase
[8,9], which then binds to BAK1, with the result that the
kinase domains activate by auto- and trans-phosphorylation of
residues in the RLK cytoplasmic domains [10–14]. The signal
is then transduced via intracellular kinases that phosphorylate
downstreamtranscriptionfactorsthataltertheexpressionofgenes
involved in cell elongation, division and differentiation [6,15,16].
Although the plant RLKs are classiﬁed as serine/threonine
protein kinases, previous results show that BRI1 and BAK1
also autophosphorylate on tyrosine residues and are thus dual-
speciﬁcity kinases [11,17]. Site-directed mutagenesis of speciﬁc
tyrosine residues in BRI1 [11,18] and BAK1 [17] followed by
in vitro biochemical analysis and an in vivo test demonstrated
that tyrosine autophosphorylation plays an important role in plant
receptor kinase function and is an important component in BR
signalling.
Ca
2+ is a universal second messenger that acts as a mediator
of stimulus–response coupling in eukaryotes. In plants, various
abiotic and biotic stimuli, including phytohormones, mechanical
and oxidative stresses, and microbial elicitors, trigger changes
in intracellular Ca
2+ concentration [19,20]. CaM (calmodulin)
is one of the primary Ca
2+-sensor proteins that can transduce
cytosolic Ca
2+ changes into a cellular response. CaM has no
enzymatic activity, but functions by changing its conformation in
t h ep r e s e n c eo fC a
2+ and concomitantly binding and altering the
activities of a wide array of target proteins [21,22]. Identiﬁcation
andcharacterizationofthephysiologicallyrelevantproteintargets
ofCaMisparticularlyimportanttounderstandhowtheseproteins
have a role in translating Ca
2+ signals into cellular responses.
In terms of BR signalling, previous studies have identiﬁed one
enzyme involved in BR biosynthesis as a Ca
2+/CaM-regulated
enzyme [23]. Interestingly, whereas several RLKs have also been
reported as binding targets of CaM [24,25], BRI1 was reported to
not interact with CaM in vitro when expressed as the recombinant
cytoplasmic domain [25]. Curiously, even when binding of CaM
to the recombinant receptor kinase cytoplasmic domains was
shown to occur, no changes in kinase activities were found,
and thus the functional signiﬁcance of CaM–RLK interactions
remains unclear.
In the present study, we show that the cytoplasmic domain of
BRI1 interacts with CaM in vitro in a Ca
2+-dependent manner.
A high-probability CaM-binding site in BRI1 was predicted to
Abbreviations used: At, Arabidopsis thaliana; AtCaMRLK, Arabidopsis thaliana calmodulin-binding receptor-like kinase; BoSRK, Brassica oleracea S
locus receptor kinase; BR, brassinosteroid; BRI1, BRASSINOSTEROID-INSENSITIVE 1; BAK1, BRI1-ASSOCIATED KINASE 1; CaM, calmodulin; CaMKII,
Ca2+/CaM-dependent protein kinase II; CLV1, CLAVATA1; CML, CaM-like; CNGC2, cyclic nucleotide-gated channel 2; IMAC, immobilized metal-afﬁnity
chromatography; LC, liquid chromatography; LRR, leucine-rich repeat; MS/MS, tandem MS; Ni-NTA, Ni2+-nitrilotriacetate; RLK, receptor-like kinase; RU,
response unit(s); SPR, surface plasmon resonance.
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occur in subdomain VIa of the kinase domain using an algorithm
basedonknownbindingproteins(http://calcium.uhnres.utoronto.
ca/ctdb/ctdb/home.html), and a synthetic peptide corresponding
to the predicted CaM-binding domain was found to interact with
CaM in vitro. We also report the novel result that co-expression
of CaM with BRI1 in Escherichia coli speciﬁcally inhibited the
kinase activity of BRI1. Both autophosphorylation of BRI1 and
BRI1-mediated transphosphorylation of E. coli proteins (which
is established as a new assay for BRI1 kinase activity) were
inhibited. Differences between CaM isoforms were observed,
suggesting speciﬁcity in the response. Our results suggest that
Ca
2+/CaM may attenuate the kinase activity of BRI1 and thereby
uncover a possible new link between Ca
2+ and BR signalling.
EXPERIMENTAL
Materials
SyntheticpeptideswithanN-terminalbiotingroupwereproduced
by GenScript and were >90% pure: W980, LNWSTRRKI-
AIGSARGLAF; W1099, LVGWVKQHAKLRISDVFD.
Pull-down assays
For pull-down experiments, His6–AtCaM7 (At is Arabidopsis
thaliana) proteins (1 μg) immobilized on 150 μlo fN i -
NTA (Ni
2+-nitrilotriacetate)–agarose beads (Qiagen) were
incubated with FLAG-tagged recombinant BRI1 protein (1 μg)
in 20 mM Mops (pH 7.5), 1 mM DTT (dithiothreitol) and
protease inhibitor mixture {4 m MN a F ,0 . 2 m MA E B S F[ 4 -
(2-aminoethyl)benzenesulfonyl ﬂuoride], 0.2 mM benzamidine,
0.2 mM caproic acid and 0.4 μME - 6 4 } for 1 h at 4◦C with
or without the addition of 100 μMC a C l 2. The agarose beads
were washed twice with a buffer of 5 mM sodium phosphate and
150 mM NaCl (pH 7.4), and then twice with the binding buffer.
Proteins were eluted using SDS/PAGE loading buffer by heating
for 5 min at 95◦C. The initial supernatant and the eluted proteins
were loaded in equal volumes on to SDS/12% polyacrylamide
gels, and immunoblots were performed with the FLAG-tag-
speciﬁc antibodies. Pull-down assays using neutravidin-coated
agarose beads (Pierce) and biotinylated synthetic peptides were
conducted using the same buffer and reaction conditions as
indicated. Brieﬂy, the biotinylated synthetic peptides (BRI1
W980) containing the putative CaM-binding site of BRI1 were
immobilized on neutravidin–agarose beads, and then incubated
with the His6–AtCaM7 protein. FLAG–BRI1 protein bound to
the beads was eluted using sample buffer and detected by
immunoblotting with anti-His6 antibodies.
Homology modelling of BRI1 kinase domain
The homology structure of the BRI1 kinase domain (residues
883–1158) was obtained with MODELLER (http://www.salilab.
org/modeller/), based on templates of tomato protein kinase
Pto (PDB code 2QKW, ∼38% identity) and human IRAK-4
(interleukin-1-receptor-associated kinase 4) (PDB code 2NRU,
∼34% identity). Structural alignment and visualization were
performed using visual molecular dynamics [26].
Protein-interaction studies
CaM binding to FLAG–BRI1 was measured using SPR (surface
plasmon resonance) with a Biacore
TM 3000 system (GE
Healthcare). A total of 300 RU (response units) of the His6–
AtCaM7 protein was immobilized on to an Ni-NTA sensorchip.
SixconcentrationsofrecombinantBRI1proteinwereindividually
passed over the sensorchip in the running buffer [20 mM Mops
(pH 7.5), 50 mM NaCl, 0.005% P20 surfactant (Biacore) and
5m MC a C l 2]a taﬂ o wr a t eo f2 0μl·min
−1 for 2 min, and the
disassociation was monitored for 10 min immediately afterwards.
Thesensorchipwasregeneratedwithrunningbufferplus300 mM
EDTA. All binding curves were normalized with a blank ﬂow cell
and a control curve of the empty analyte injection. The Kd values
were calculated assuming a 1:1 or 1:2 (CaM/BRI1) ratio with
the Langmuir model. For the 1:2 ratio calculation, the molecular
mass of analyte FLAG–BRI1 was taken as 88 kDa corresponding
to the putative dimeric protein. The global ﬁtting procedure of the
software BIAevaluation 3.0 was used to calculate the Kd value
using data from the six binding curves.
LC (liquid chromatography)-MS/MS (tandem MS) analysis
Denatured E. coli soluble proteins were digested with trypsin
(Promega) and sequentially enriched for phosphopeptides using
TiO2 (PierceTiO2 PhosphopeptideEnrichmentandClean-UpKit)
followed by IMAC (immobilized metal-afﬁnity chromatography)
(PHOS-Select Iron Afﬁnity gel, Sigma–Aldrich). The insoluble
protein fraction (referred to as ‘P-bodies’ in Supplementary Table
S1 at http://www.BiochemJ.org/bj/443/bj4430515add.htm) was
treatedsimilarly.LC–MS/MSanalysiswasperformedonaWaters
Q-TofAPI-USquadrupole–time-of-ﬂightmassspectrometerwith
ananoAcquityUPLC(ultra-performanceliquidchromatography)
system, with a linear gradient of 1–60% acetonitrile in 0.1%
formic acid over 60 min. MS/MS data were collected using the
Data Directed Analysis method in MassLynx to fragment the top
four ions in each survey scan. Spectra were searched in MAS-
COT (http://www.matrixscience.com/search_form_select.html)
against the NCBI non-redundant database limited to E. coli.
Fluorescence spectroscopy
Fluorescence spectra were acquired at room temperature
(21+ −1◦C) with a PTI QuantaMaster4 spectroﬂuorimeter (Photon
Technology) using excitation and emission bandwidths of
5 nm. The tryptophan residues of BRI1 W980 peptide were
excited at 285 nm, and ﬂuorescence emission was measured
from 300 to 450 nm. Peptide concentrations were either 1 or
2 μM. Measurements were made in buffer consisting of 20 mM
Hepes/KOH (pH 7.2), 100 mM KCl and 1 mM CaCl2 or 5 mM
EDTA. Puriﬁed recombinant CaM was prepared as described
previously [27] and added as described in the Figure legends.
For each concentration of CaM tested, the ﬂuorescence of
a blank consisting of identical reagents minus peptide was
recorded and subtracted from the corresponding ﬂuorescence
spectrum containing peptide using the instrument software to
account for the small contribution of ﬂuorescence from the
phenylalanine and tyrosine residues of CaM. Spectra were
exported from the instrument software to Origin v8.0 for graphic
presentation.
Dansylated CaM was prepared as described in [28].
Fluorescence of the modiﬁed protein was excited at 335 nm
and emission was recorded from 400 to 600 nm. Fluorescence
was measured in 20 mM Hepes/KOH (pH 7.2) and 100 mM
KCl containing 150 nM dansylated CaM and recorded after
sequential additions of 1 mM CaCl2, 300 nM peptide and
5 mM EDTA. Peptides representing the CaM-binding domains
of CaMKII (Ca
2+/CaM-dependent protein kinase II) and
Arabidopsis CNGC2 (cyclic nucleotide-gated channel 2) were
purchased from EMD Chemicals and GenScript respectively.
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Co-expression of CaM and BRI1 in E. coli
E. coli cells co-expressing CaM and recombinant FLAG–BRI1
proteins were prepared by transformation of plasmids designed
to express CaM proteins into E. coli BL21(DE3) pLysS cells
(Novagen) harbouring a FLAG–BRI1 expression plasmid. The
recombinant BRI1 cytoplasmic domain was expressed from a
high-copy-number plasmid under the control of an inducible tac
promoter. AtCaM proteins were constitutively expressed from a
modiﬁed version of pACYC184, a low-copy-number plasmid,
containing a p15A origin which allows it to coexist in cells
with plasmids of the ColE1 compatibility group such as pBR322
[29]. Constitutive CaM expression driven by this plasmid in
E. coli was conﬁrmed by extracting soluble proteins and CaM
proteins as described previously [27] (Supplementary Figure
S1athttp://www.BiochemJ.org/bj/443/bj4430515add.htm).CaM
proteins were expressed by this construct in E. coli at
approximately 1 μg/mg of soluble protein, which is comparable
with CaM concentrations in extracts from plants [30].
Recombinant protein puriﬁcation and immunoblot analysis
Puriﬁcation of FLAG–BRI1 protein was performed as described
in [11] using anti-FLAG M2 afﬁnity gel. Autophosphorylation
of the recombinant BRI1 proteins puriﬁed from co-expressing
E. coli cells was analysed by immunoblotting after transfer
on to PVDF membranes using Pro-Q Diamond phosphoprotein
stain(Invitrogen),anti-phosphotyrosineoranti-phosphothreonine
antibodies with the detection of immune complexes using
ﬂuorescent secondary antibodies (Invitrogen) as described in
[11]. Immunoblotting was carried out as described in [31], and
densitometry was performed using an Odyssey Infrared Imaging
System (LI-COR Bioscience) to quantify immunoblot results.
Relative autophosphorylation levels of BRI1 co-expressed with
CaM were calculated as the ratio of the speciﬁc phosphorylation
signal to the anti-FLAG or Coomassie Brilliant Blue-stained
protein signal and the values obtained with the control FLAG–
BRI1cytoplasmicdomainexpressedaloneinE.coliweresetas1.
RESULTS AND DISCUSSION
Ca2+-dependent binding of CaM to the BRI1 kinase domain
The interaction of CaM with the BRI1 cytoplasmic domain and
its Ca
2+-dependence were tested by pull-down assays (Figure 1).
When His6–AtCaM7 was immobilized on Ni-NTA–agarose
beads, recombinant FLAG–BRI1 protein bound to the beads in
thepresenceofCa
2+ (Figure1A).Nobindingwasobservedinthe
absence of Ca
2+ or to the Ni-NTA–agarose beads in the absence
of bound AtCaM7 (bead control, Figure 1A). Interestingly, CaM
binding occurred primarily to the hypophosphorylated form of
BRI1 (Figure 1A). In the supernatant fraction, the characteristic
upperandlowerbandsoftheFLAG–BRI1protein(corresponding
to hyper- and hypo-phosphorylated forms respectively) were
clearly apparent as visualized by an approximate 1:2.9 ratio
in densitometry, but primarily the lower band was retained on
the AtCaM7-afﬁnity resin (1:15 ratio in densitometry between
hyper- and hypo-phosphorylated forms). These results suggest
that phosphorylation, perhaps of speciﬁc sites, of BRI1 inhibits
CaM binding. In order to determine which portion of the BRI1
cytoplasmic domain contained the CaM-binding site, a pull-down
experiment was performed with truncated BRI1 proteins lacking
either or both of the domains ﬂanking the kinase domain. As
shown in Figure 1(B), all of the truncated proteins bound to
Figure 1 Interaction of CaM with BRI1
(A)BindingofFLAG–BRI1toAtCaM7–Ni-NTA–agarosebeadsinthepresence(+)orabsence
(−)o fC a 2+. The ‘bead control’ refers to FLAG–BRI1 applied to Ni-NTA beads alone, and
‘CaM + BRI1’ refers to FLAG–BRI1 applied to AtCaM7–Ni-NTA–agarose beads. Proteins
retained by the beads were eluted with sample buffer and analysed by SDS/PAGE followed by
immunoblotting (IB) with anti-FLAG antibodies. (B) Schematic map of the truncated BRI1-CD
domains (KD, KDCT, JMKD and CD) and their binding to AtCaM7–Ni-NTA–agarose beads in
the presence (+) or absence (−)o fC a 2+ as judged by SDS/PAGE and immunoblotting
(IB) using anti-FLAG. JM, juxtamembrane region; KD, kinase domain; CT, C-terminal region.
Molecular masses are indicated in kDa.
immobilized AtCaM7, suggesting that the CaM-binding site was
located within the kinase domain of BRI1.
We conﬁrmed the binding of BRI1 and CaM using real-
time measurements of protein–protein interaction. As shown
in Figure 2, immobilized His6–CaM7 bound FLAG–BRI1
cytoplasmic domain protein in the presence of Ca
2+.T h e
calculated Kd value was ∼58 nM, which is similar to the binding
constantforotherCaM-interactingproteins,and,whencalculated
at a 1:2 (CaM/BRI1) binding ratio (see Figure 5), the Kd value
was reduced to 13 nM.
CaM binds to BRI1 kinase subdomain VIa
Using algorithms for predicting CaM-binding domains [32], we
identiﬁed a potential CaM-binding region in the BRI1 kinase
domain (Supplementary Figure S2 at http://www.BiochemJ.
org/bj/443/bj4430515add.htm). The sequence contains a
tryptophan residue, which is often, but not always, found in
CaM-binding sites, and structural modelling of the BRI1 kinase
domain suggested that this region resides in surface-localized
α-helix E of BRI1 kinase subdomain VIa (Supplementary Fig-
ure S3 at http://www.BiochemJ.org/bj/443/bj4430515add.htm).
A basic amphiphilic α-helix structure is one of the common
features found in most CaM-binding proteins characterized [33].
To test whether the predicted sequence could bind CaM, a
syntheticpeptide(designatedW980fromAla
974 toPhe
996 ofBRI1)
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Figure 2 SPR analysis of the CaM–BRI1 interaction
The real-time CaM–BRI1 interaction was analysed by SPR using a BiacoreTM 3000 system. The
ligand was His6–AtCaM7 protein that was immobilized (∼300 RU) and the indicated
concentrations of FLAG–BRI1 cytoplasmic domain protein were applied as analyte. The
disassociation was monitored for 10min, but only the ﬁrst 6 min are shown. Binding curves
were normalized with a blank ﬂow cell and a control curve of empty analyte injection, and the
Kd value was calculated with the Langmuir model in BIAevaluation 3.0 using data from the six
binding curves.
spanning the potential CaM-binding domain was immobilized
and tested for CaM binding in a pull-down assay (Figure 3A). As
predicted, the W980 peptide interacted with His6–AtCaM7 and
the binding was strongly Ca
2+-stimulated; densitometry of the
retained CaM7 in the presence of Ca
2+ was 2.7-fold greater than
the CaM7 retained in the beads without Ca
2+.
As an independent approach, the binding of the W980
peptide to dansylated AtCAM2 was assessed by monitoring
ﬂuorescence of the dansyl ﬂuor, which has the advantage that
both molecules are free in solution. As shown in Figure 3(C), the
W980 peptide increased the dansyl-CaM ﬂuorescence emission
and blue-shifted the ﬂuorescence maximum in the presence of
Ca
2+. Addition of EDTA to the peptide–Ca
2+/CaM mixture
reduced the ﬂuorescence emission, suggesting that the interaction
between CaM and the W980 peptide was Ca
2+-dependent. This
ﬂuorescence enhancement and Ca
2+-sensitivity of dansylated
CaM exerted by the W980 peptide was similar to that elicited
frompeptidesderivedfrompreviouslyestablishedCaM-regulated
proteins, mammalian CaMKII [34] (Figure 3D) and Arabidopsis
CNGC2[35](Figure3E).Asanadditionalcontrol,anotherkinase
domain sequence that contains a tryptophan residue (designated
W1099 from Leu
1096 to Glu
1115 of BRI1) was produced and tested
for binding to dansylated CaM2. As shown in Figure 3(B),
there were some shifts in the ﬂuorescence emission spectrum
in the complete reaction, indicating some interaction in vitro,b u t ,
overall, the changes were substantially reduced compared with
the W980 peptide or the positive control peptides (Figures 3D
and 3E).
As a second independent approach to assess the interaction of
the W980 peptide with CaM in vitro, we monitored the intrinsic
ﬂuorescence of the tryptophan residue in the W980 peptide. This
assay can be used because CaM itself does not contain tryptophan
residues. Fluorescence emission of the indole ring of tryptophan
is a sensitive indicator of its surroundings: when tryptophan is in
an aqueous environment, it ﬂuoresces maximally around 355 nm,
whereaswhenitisburiedinahydrophobicregion,itsﬂuorescence
is enhanced and also blue-shifted [36]. Figure 4(A) shows that
when recombinant AtCaM2 was mixed with the W980 peptide
in the presence of Ca
2+, ﬂuorescence emission was enhanced
and its maximum was blue-shifted to 327 nm. Conversely, EDTA
Figure3 CaMinteractionwithpeptidesderivedfromBRI1andknownCaM-
binding proteins
(A)BindingofHis6–AtCaM7toimmobilizedbiotin–W980peptideboundtoneutravidin–agarose
beads in the presence (+) or absence (−)o fC a 2+.H i s 6–AtCaM7 proteins that bound were
subsequently eluted and subjected to SDS/PAGE and immunoblotting (IB) using anti-His6
antibodies. A molecular mass of 17kDa is indicated. (B–E) Dansylated AtCaM2 (500nM) in
20mM Hepes/KOH (pH7.2) and 100mM KCl was incubated with a 2-fold molar excess of
peptides derived from (B) BRI1 W1099, (C) BRI1 W980, (D)C a M K I Io r( E) CNGC2. Dansylated
CaM ﬂuorescence was excited at 335nm and emission was measured from 400 to 600nm. In
eachpanel,trace‘a’(continuousline)isthespectrumofdansyl-CaM+Ca2+,trace‘b’(dashed
line) is dansyl-CaM+Ca2+ +peptide, and trace ‘c’ (dotted line) is the mixture after chelating
the Ca2+ with EDTA.
addition reduced ﬂuorescence and red-shifted the maximum to
350 nm. Similar results were obtained with AtCaM4, AtCaM6
and AtCaM7 (Figures 4B–4D). This conﬁrms that binding occurs
and suggests further that the indole ring of Trp
980 in the peptide is
buriedinahydrophobicpocketofCaMwhenthetwointeract.The
lack of a shift in the ﬂuorescence emission spectrum of the W980
peptide in the presence of AtCML8 or AtCML9 suggests either
that these CML (CaM-like) proteins do not bind to the peptide or
that the binding pocket does not position the tryptophan residue
in a hydrophobic environment. Nevertheless, two independent
in-solution ﬂuorescence-based assays along with demonstration
of binding to an immobilized peptide are consistent with the
computational prediction of the CaM-binding site as helix E of
BRI1 kinase subdomain VIa.
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Figure 4 Steady-state tryptophan ﬂuorescence of the BRI1 W980 peptide
in the presence of various CaM and CML isoforms
Intrinsic tryptophan ﬂuorescence of the W980 peptide was measured in 20mM Hepes/KOH
(pH7.2), 100mM KCl and 1mM CaCl2 in the presence of (A) AtCaM2 (Z12023), (B)A t C a M 4
(Z12022), (C) AtCaM6 (Z12024), (D) AtCaM7 (U82119), (E) AtCML8 (U84678) or (F)A t C M L 9
(U12490) (GenBank® accession numbers are given within parentheses). In each experiment,
emission of 1μM W980 peptide was measured in the absence of CaM or CML proteins
(continuouslines,a)andaftersequentialadditionof600nMprotein(dashedlines,b)and5mM
EDTA (dotted lines, c).
Steady-state ﬂuorescence titrations of AtCaM6 with the W980
peptide in the presence of Ca
2+ were measured because the
AtCaM6–W980 peptide combination gave the most robust
changes in ﬂuorescence (Figure 4C). The results of this
experiment, shown in Figure 5, suggest that the stoichiometry
of the AtCaM6–W980 complex is 2:1. To conﬁrm this result, we
carriedoutgel-shiftassays[37]onmixturesofAtCaM6andW980
peptide. As shown in Supplementary Figure S4 (http://www.
BiochemJ.org/bj/443/bj4430515add.htm), the mobility of At-
CaM6 in a non-denaturing gel containing Ca
2+ was reduced in
the presence of the W980 peptide; the mobility shift saturated
at 2 mol equivalents of W980 peptide per mol of AtCaM6. In
contrast, the mobility of AtCaM6 was quantitatively shifted in
the presence of 1 mol equivalent of a peptide derived from the
CaM-binding domain of mammalian CaMKII, a result that is
consistent with the known atomic level structure of the CaM–
CaMKII complex [34]. The contrast in sharpness between the
AtCaM6 complexes with W980 and CaMKII peptides probably
reﬂects their differences inafﬁnity for AtCaM6. Nevertheless, the
result is consistent with the idea that the AtCaM6–W980 binding
stoichiometry is 2:1. Although somewhat atypical, there are other
examples where CaM binds to two polypeptides rather than just
one [38]. This could indicate that Ca
2+/CaM-mediated signalling
may function in some capacity to regulate BRI1 dimerization, but
further experiments will be required to test this notion.
Figure 5 Stoichiometry of binding of AtCaM6 to the W980 peptide using
steady-state tryptophan ﬂuorescence
IntrinsictryptophanﬂuorescenceofW980(2μM)wasmeasuredin20mMHepes/KOH(pH7.2),
100mM KCl and 1 mM CaCl2 following sequential additions of CaM6. Only the curves for 0
(continuous line) and 1 (broken line) mol equivalent of CaM6 are shown for clarity. The
inset shows the change in ﬂuorescence intensity ( Fluorescence) at λmax of the CaM6–W980
complex plotted against the [CaM6]/[W980] ratio. The data were ﬁtted by a Boltzmann function
to produce a binding curve using Origin (version 8.0).
AtCaM6 binding does not affect BRI1 kinase activity in vitro
We tested the effect of Ca
2+/CaM on BRI1 peptide kinase
activity using the SP11 synthetic peptide as substrate [10].
As shown in Supplementary Figure S5 (http://www.BiochemJ.
org/bj/443/bj4430515add.htm), addition of increasing concentra-
tions of AtCaM6 in the presence or absence of Ca
2+ had no
signiﬁcanteffectontransphosphorylationofthesyntheticpeptide.
Likewise, previous studies found no effect of CaM binding to
BoSRK (Brassica oleracea S locus receptor kinase) [25] or
AtCaMRLK (At CaM-binding RLK) [24].
Co-expression of CaM and BRI1 in E. coli inhibits
autophosphorylation of BRI1
Another assay of BRI1 kinase activity is autophosphorylation;
however, analysis of autophosphorylation in short reactions
in vitro [10] does not completely reﬂect the process that occurs in
planta or when recombinant protein is expressed in E. coli [11].
Accordingly, to assess whether autophosphorylation of BRI1 is
affected by CaM, we co-expressed the two proteins in E. coli and
then examined BRI1 autophosphorylation by immunoblotting.
As a control, we co-expressed 14-3-3ω, which also binds to
the BRI1 cytoplasmic domain (M.-H. Oh, X. Wu and S. C.
Huber,unpublishedwork).AsshowninFigure6,co-expressionof
CaM with BRI1 altered the pattern of BRI1 autophosphorylation,
and, in general, tyrosine autophosphorylation (pTyr in the
Figure) of BRI1 was inhibited more strongly than threonine
autophosphorylation or overall autophosphorylation as assessed
by Pro-Q Diamond phosphoprotein staining. All CaM isoforms
tested had some effect, but CaM6, CaM7 and CML8 were
more effective than were CaM2, CaM4, CML11 (GenBank®
accession number U14842) and 14-3-3ω. The inhibition of BRI1
autophosphorylation is evident from the immunoblot and stain
results shown in Figure 6(A), and as quantiﬁed in Figure 6(B),
where values were normalized for BRI1 protein (Coomassie
Brilliant Blue staining). Importantly, the expression of the diffe-
rent CaM isoforms did not vary appreciably as shown in the
bottompanelofFigure6(A),indicatingthatdifferencesinisoform
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Figure 6 Inhibition of BRI1 autophosphorylation by co-expression of CaM
(A) Co-expression of individual CaM or CML isoforms with recombinant BRI1 cytoplasmic
domain (CD) in E. coli cultured in LB (Luria–Bertani) medium containing 1mM CaCl2.
FLAG–BRI1-CD proteins were separated by SDS/PAGE and analysed for total phosphorylation
by Pro-Q staining or for more speciﬁc phosphorylation on tyrosine or threonine residues by
immunoblotting (IB) using generic antibodies as indicated. Results are representative of four
independentexperiments.MolecularmassesareindicatedinkDa.(B)Theresultsobtainedfrom
immunoblotting were quantiﬁed as the relative autophosphorylation levels on tyrosine (black
bars) or threonine (white bars), normalized for Coomassie Brilliant Blue (CBB)-stained protein,
and values for the BRI1 control were set at 1. *P  0.05 relative to the BRI1 control using
Student’s t test.
effectiveness cannot be ascribed to variation in expression level.
It is also worth noting that the production of recombinant BRI1
proteinwasnotappreciablyalteredbyco-expressionofthesecond
protein (results not shown). These results suggest that interaction
with certain CaM isoforms inhibits BRI1 autophosphorylation
and that phosphorylation of tyrosine residues may be affected
more than serine and threonine residues.
Co-expression of CaM and BRI1 in E. coli inhibits
transphosphorylation of bacterial proteins
During the production of recombinant BRI1 protein in E.
coli, bacterial proteins are phosphorylated, which provides a
novel assay for the transphosphorylation activity of the BRI1
cytoplasmic domain. The assay has been characterized (details
are available from S.C.H. on request), but, in the present paper,
we document the basic occurrence of this activity only. After 16 h
ofBRI1induction,numerousE.coliproteinswerephosphorylated
as was evident by immunoblotting and Pro-Q Diamond
phosphoprotein staining (Figure 7). The phosphorylation of
bacterial proteins was dependent on the kinase activity of BRI1,
because when the kinase-inactive BRI1(K911E) mutant was
expressed, essentially no phosphorylation of E. coli proteins
wasobserved(SupplementaryFigureS6athttp://www.BiochemJ.
org/bj/443/bj4430515add.htm).ThesamplesanalysedinFigure6
had the majority of the FLAG–BRI1 protein removed by afﬁnity-
puriﬁcation, but some of the BRI1 protein was still apparent
at the position expected for a ∼50 kDa protein (Figure 7). The
most important result is that co-expression of the CaM isoforms
inhibited the transphosphorylation of E. coli proteins. This was
most apparent with AtCaM6, AtCaM7 and AtCML8, which
almost completely inhibited transphosphorylation on threonine
and tyrosine residues. The strong reduction in Pro-Q Diamond
staining also suggests that serine phosphorylation was also
inhibited. Importantly, co-expression of 14-3-3ω had no apparent
effectonthetransphosphorylationactivityofBRI1,indicatingthat
the effects observed with CaM co-expression were speciﬁc. The
CaM isoform speciﬁcity for inhibition of autophosphorylation
(Figure 6) was generally similar to that for transphosphorylation
(Figure7),conﬁrmingthenotionthatCaMbindingtoBRI1insitu
attenuated kinase activity. Interestingly, these results also suggest
that the lack of apparent binding of CML8 to the W980 peptide
in vitro (Figure 4E) probably means that the binding pocket of
CML8 does not position the tryptophan residue in a hydrophobic
environment and therefore the ﬂuorescence emission spectrum is
unaltered.
To ﬁrmly establish the BRI1-mediated transphosphorylation of
E. coli proteins, samples such as those used in the immunoblot
analysis presented in Figure 7 were digested with trypsin and
phosphopeptides were enriched with TiO2 or IMAC before
analysis by LC–MS/MS. The two enrichment protocols are
considered to be complementary [39–41]. Combining all of
the results obtained in the present study, a total of 77 unique
phosphopeptides consisting of 104 individual phosphorylation
siteswereidentiﬁed.Thesitesweredistributedamong41different
E. coli proteins that included many enzymes involved in gene
expression, translation, protein folding and metabolism. One
example is illustrated in Figure 8(A), but a complete list of
the phosphopeptides identiﬁed is provided in Supplementary
Table S1. As shown in Figure 8(A), the DNA-binding protein
hupA was phosphorylated on seven distinct residues that were
observedinsixdifferentphosphopeptides.Interestingly,theseven
phosphorylation sites were located in either the N-terminal or
the C-terminal region of the protein. The results with hupA
also illustrate that our analysis identiﬁed phosphopeptides that
included single, doubly and triply phosphorylated peptides, with
a predominance of doubly phosphorylated species (Figure 8B).
From analysis of the multiply phosphorylated peptides, the
number of residues between phosphorylation sites ranged from
zero (i.e. adjacent phosphosites) to nine, with the largest number
having four intervening residues (Figure 8C). These results are
important because they ﬁrmly establish this new assay for BRI1-
mediated transphosphorylation and perhaps will give insights
into the nature of the sites targeted by BRI1, and, in this
regard, the predominance of multiply phosphorylated peptides
was certainly unexpected. It is important to note that bacterial
cells do have endogenous protein phosphorylation on serine,
threonine and tyrosine residues, although at much lower levels
thanineukaryotes.Inanintensivesurvey[42],81phosphorylation
sites on 79 E. coli proteins were identiﬁed, and two of these
endogenous phosphosites were detected in our study: Ser
19 of
rpmB and Ser
453 of dnaK. It is possible that these sites were
also targets of BRI1, but it is clear that the vast majority of the
sitesreportedinSupplementaryTableS1werephosphorylatedby
BRI1 rather than endogenous bacterial protein kinases.
Concluding remarks
We have shown that Ca
2+/CaM binds to the recombinant BRI1
cytoplasmic domain protein in vitro and have identiﬁed a likely
binding site in subdomain VIa. Interestingly, a previous study
found that CaM binds to BoSRK [25] at the equivalent site
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Figure 7 Inhibition of BRI1-mediated transphosphorylation of E. coli proteins by co-expression of CaM proteins
Following afﬁnity-puriﬁcation of FLAG–BRI1 protein from cultures co-expressing CaM or CML isoforms, aliquots (containing 15μg of predominantly E. coli proteins) of the remaining protein
fraction were separated by SDS/PAGE and analysed for phosphorylation as described in Figure 6. w, 14-3-3ω; CBB, Coomassie Brilliant Blue; IB, immunoblotting. Molecular masses are indicated
in kDa.
in subdomain VIa and because of general conservation of this
region, these authors suggested that CaM may interact with other
receptor kinases. Indeed, binding of CaM to RLK4 and CLV1
(CLAVATA1) was demonstrated, but BRI1 was reported to not
bind [25]; the basis for the discrepancy in results with BRI1 is
not clear. However, what is emerging is that CaM appears to
interact broadly with plant receptor kinases, including BoSRK,
AtRLK4 and AtCLV1 [25], AtCaMRLK [24] and, in the present
study, BRI1. Previous studies reported that CaM had no effect
on the activity of these kinases, and thus our demonstration that
CaM inhibits BRI1 kinase activity when co-expressed in E. coli
provides the ﬁrst information about a possible functional impact
of CaM binding. The inhibition of BRI1 autophosphorylation
and transphosphorylation activity by co-expression of certain
CaM isoforms provides compelling evidence for the notion
that CaM binding affects BRI1 kinase activity. Moreover, the
results uncover a possible link between Ca
2+ and BR signalling
that will provide the foundation for future studies.
In the present study, we also established a new assay
for monitoring transphosphorylation activity of recombinant
receptor kinase cytoplasmic domains. This assay is based on
the phosphorylation of E. coli proteins in situ as a result of
expression of the recombinant protein kinase and is documented
in the present study for BRI1. The assay will almost certainly will
have relevance to studies with other receptor kinases as well.
In the present study, we have established by immunoblotting
that BRI1 phosphorylates numerous E. coli proteins on serine,
threonine and tyrosine residues (Figure 7). Many speciﬁc serine
and threonine phosphosites on E. coli proteins were identiﬁed
by LC–MS/MS (Figure 8 and Supplementary Table S1). It is not
clear why we were unable to identify any tyrosine phosphosites,
but this perhaps reﬂects their lower relative abundance compared
with serine/threonine phosphosites. Of particular relevance to the
presentstudy,weusedthenewassaytodemonstratetheinhibitory
effect of CaM on BRI1-mediated transphosphorylation activity
(Figure 7). Isoforms of CaM and CML proteins differed in their
effectiveness and those that inhibited transphosphorylation also
inhibited BRI1 autophosphorylation. We observed that AtCaM6
and AtCaM7 were more effective than were AtCaM2 and
AtCaM4, and, indeed, CaM6 and CaM7 are most similar to one
another in sequence [43]. Interestingly, CML8 was as effective
as CaM6 and CaM7 (Figures 6 and 7), suggesting that non-
canonical CaM-like proteins may play a role in BRI1 regulation
aswell.AlthoughtheCMLfamilyhas50members,CML8andits
paralogue CML11 are most closely related to the CaM proteins,
butdifferedstrikinglyintheirabilitytoaffectBRI1kinaseactivity,
with CML11 being inactive. Thus subtle sequence differences
can have dramatic effects, as has been observed previously for
interactions of CaM isoforms with their target proteins [44,45].
The results of the present study raise many important questions
that remain to be addressed. First, do BRI1 and CaM/CML
proteins interact in vivo, and, if so, under what conditions?
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Figure 8 Identiﬁcation of BRI1-mediated transphosphorylation sites on E. coli proteins
(A)RepresentativeLC–MS/MSresultsidentifyingBRI1-mediatedphosphorylationsitesontheDNA-bindingproteinhupA,obtainedbyenrichmentofphosphopeptidesusingTiO2 (TiO)orFe3+-IMAC
(IMAC)asindicated.ThecompletelistofphosphositesidentiﬁedispresentedinSupplementaryTableS1athttp://www.BiochemJ.org/bj/443/bj4430515add.htm.Mr(expt),expectedmolecularmass;
Mr(calc),calculatedmolecularmass;MC,thenumberofmissedcleavages;Score,Mascotscore,whichisaprobability-basedimplementationoftheMowsealgorithm.Thetotalscoreistheabsolute
probability that the observed match is a random event and is calculated as −10·log10(P), where P is the absolute probability. Expect, expectation value, which is directly equivalent to the E-value
in a BLAST search result. The lower the expectation value, the more signiﬁcant the score. (B) Number of residues between adjacent phosphosites in multiply phosphorylated peptides. (C) Number of
singly, doubly or triply phosphorylated peptides identiﬁed.
Presumably the interaction is regulated by increased cytosolic
Ca
2+ concentrations, which could occur under stress conditions
[46,47] or in response to BR signalling [48]. Another important
questioniswhethertheinhibitionoftransphosphorylationactivity
by Ca
2+/CaM binding to BRI1 occurs as a result of the inhibition
of autophosphorylation. This is our current working model
(Supplementary Figure S7), which we believe explains why
addition of CaM in vitro had no effect on BRI1 peptide kinase
activity (Supplementary Figure S5). If correct, then a rise in
cytosolic Ca
2+ concentration that occurs after the receptor kinase
has fully activated would have no immediate consequence on
kinase activity, but rather would inhibit the subsequent activation
of additional BRI1 molecules. Another crucial area for future
research will be to identify all of the downstream cytoplasmic
targets (e.g. other protein kinases) that are transphosphorylated
directly by BRI1 in vivo in Arabidopsis cells, the inﬂuence of
phosphorylation ontheir biological functions, androles that Ca
2+
and CaM or CML proteins may have in this process, particularly
in plants acclimating to biotic or abiotic stress. Although many
questions remain, the new insights obtained provide a working
model and foundation for continued studies. Moreover, the co-
expression system in E. coli may be useful for studies of CaM
andotherproteinsaspotentialinteractorswithavarietyofreceptor
kinases.
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Figure S1 Constitutive expression of CaM in E. coli driven by pRZ528
(CaM7) and 529 (CML8)
Total soluble proteins were extracted from late-exponential-phase bacteria, clariﬁed by
centrifugationandsubjectedtoCa2+-dependentHIC(hydrophobicinteractionchromatography)
on phenyl-Sepharose. Samples of the crude extract, the fraction that did not bind to
phenyl-Sepharose (unbound), and the fraction that eluted from the resin in the presence of
EDTA(bound)wereseparatedbySDS/PAGEandstainedwithCoomassieBrilliantBlue.Puriﬁed
AtCaM and recombinant CaM (rCaM) were fractionated in parallel as positive controls together
with molecular mass standards (Stds, sizes given in kDa).
Figure S2 BRI1 cytoplasmic domain sequence showing predicted
probabilities of CaM binding
The numbers below the sequence indicate the probability of CaM binding (http://calcium.
uhnres.utoronto.ca/ctdb/ctdb/home.html) with 9 being the highest score. The kinase domain of
BRI1 is shown in red, and the sequences used to generate the W980 and W1099 peptides are
underlined.
1 To whom correspondence should be addressed (email schuber1@illinois.edu).
c   The Authors Journal compilation c   2012 Biochemical Society © 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.M.-H. Oh and others
Figure S3 Model of the BRI1 kinase domain structure
The BRI1 kinase domain was modelled as described in the Experimental section of the main
text. The location of the predicted CaM-binding site (Leu978–Arg992) is shown in yellow and the
Try980 side chain is shown in red. (A) Front view. (B) Side view.
Figure S4 Gel mobility-shift analysis of AtCaM6 interaction with W980
peptide
AtCaM6(300pmol/reaction)wasincubatedwith0(lane1),150(lane2),300(lane3),600(lane
4) or 1200 (lane 5) pmol of W980 peptide or 300pmol of a CaM-binding peptide from CaMKII
(lane 6) then fractionated in a non-denaturing gel containing Ca2+. Coomassie Brilliant Blue
stainingrevealedthemigrationoffree(F)andpeptide-bound(B)AtCaM6.Thelargersizeofthe
CaMKII peptide resulted in a slower mobility of the peptide–AtCaM6 complex compared with
the W980 peptide complex.
Figure S5 AtCaM6 has no effect on BRI1 peptide kinase activity in vitro
BRI1 peptide kinase activity was assayed using [32P]ATP and the SP11 synthetic peptide as
substrate as described in [1] with the addition of 0.1mM CaCl2 or 1 mM EGTA as indicated.
Each reaction contained 0.5μg of FLAG–BRI1 protein, and reactions were run for 5 min.
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Figure S6 Kinase-inactive mBRI1 does not transphosphorylate E. coli proteins
BRI1 or the kinase-inactive mBRI1 (mutant BRI1) were expressed in E. coli and following puriﬁcation of the FLAG-tagged proteins, the remaining E. coli proteins were analysed for phosphorylation
by Pro-Q Diamond phosphoprotein staining or immunoblotting (IB) with generic anti-phosphotyrosine or anti-phosphothreonine antibodies. Molecular masses are indicated in kDa.
Figure S7 Working model for effects of Ca2+/CaM on BRI1
We propose that Ca2+/CaM inhibits BRI1 autophosphorylation, which then affects
transphosphorylation activity. Thus certain CaM and CML isoforms inhibit BRI1
autophosphorylation when co-expressed in E. coli and, as a result, also inhibit the
transphosphorylation of E. coli proteins. This provides a plausible explanation for why
Ca2+/CaM inhibits transphosphorylation in the in situ system, but does not affect
transphosphorylation activity in vitro (peptide kinase activity). The model predicts that Ca2+
signalling during early stages of BRI1 activation will attenuate downstream signal transduction.
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Table S1 Identiﬁcation of BRI1-mediated phosphorylation sites on E. coli proteins
LC–MS/MSresultsidentifyingBRI1-mediatedphosphorylationsitesonE.coli proteins,obtainedbyenrichmentofphosphopeptidesusingTiO2,Fe 3+-IMAC(IMAC)orprocessingbodies(P-bodies)
asindicated.Mr(expt),expectedmolecularmass;Mr(calc),calculatedmolecularmass;MC,thenumberofmissedcleavages;Score,Mascotscore,whichisaprobability-basedimplementationofthe
Mowse algorithm. The total score is the absolute probability that the observed match is a random event and is calculated as −10·log10(P), where P is the absolute probability. Expect, expectation
value, which is directly equivalent to the E-value in a BLAST search result. The lower the expectation value, the more signiﬁcant the score.
Source Site Name Mr(expt) Mr(calc) Delta MC Score Expect Peptide
TiO2 Thr4 hupA 1581.3848 1581.7837 −0.3989 1 101 1.40×10−8 -.MNKpTQLIDVIAEK.A
IMAC Thr19 hupA 1054.2634 1054.506 −0.2425 1 30 0.018 K.AELSKpTQAK.A
IMAC Ser17/Thr19 hupA 1134.2084 1134.4723 −0.2638 1 45 0.00029 K.AELpSKpTQAK.A
TiO2 Ser27/Thr33 hupA 1676.3594 1676.7674 −0.4080 0 53 2.40×10−5 K.AALEpSTLAAIpTESLK.E
TiO2 Thr28/Thr33 hupA 1676.3608 1676.7674 −0.4066 0 57 8.90×10−6 K.AALESpTLAAIpTESLK.E
TiO2 Ser81 hupA 1323.3224 1323.6588 −0.3363 0 79 2.00×10−7 K.IAAANVPAFVpSGK.A
TiO2 Ser4 hupB 1155.2196 1155.5359 −0.3162 1 40 0.016 -.MNKpSQLIDK.I
P-bodies Ser4 hupB 1024.2108 1024.4954 −0.2845 1 43 0.0008 M.NKpSQLIDK.I
TiO2 Thr65/Thr70 hupB 1600.3228 1600.7263 −0.4034 1 109 7.00×10−10 R.NPQpTGKEIpTIAAAK.V
TiO2 Ser21 groS 1281.3088 1281.6330 −0.3241 0 65 1.80×105 K.pSAGGIVLTGSAAAK.S
TiO2 Thr28 groS 1281.3080 1281.6330 −0.3249 0 43 0.00041 K.SAGGIVLpTGSAAAK.S
TiO2 Ser21/Thr28 groS 1361.2596 1361.5993 −0.3396 0 89 3.70×10−8 K.pSAGGIVLpTGSAAAK.S
TiO2 Ser21/Ser30 groS 1361.2416 1361.5993 −0.3576 0 74 1.70×10−6 K.pSAGGIVLTGpSAAAK.S
TiO2 Ser28 lacI 1218.2710 1218.5758 −0.3047 0 47 8.30×105 R.VVNQApSHVSAK.T
TiO2 Ser28/Ser31 lacI 1298.1776 1298.5421 −0.3645 0 74 4.20×10−7 R.VVNQApSHVpSAK.T
TiO2 Ser28/Thr34 lacI 1555.2901 1555.6909 −0.4008 1 75 4.40×10−7 R.VVNQApSHVSAKpTR.E
TiO2 Ser31/Thr34 lacI 1555.3120 1555.6909 −0.3789 1 78 7.70×10−7 R.VVNQASHVpSAKpTR.E
TiO2 Ser28/Ser31/Thr34 lacI 1635.2568 1635.6572 −0.4004 1 96 6.40×10−9 R.VVNQApSHVpSAKpTR.E
TiO2 Ser93/Ser97 lacI 1719.3072 1719.7304 −0.4231 0 49 0.00021 R.ADQLGApSVVVpSMVER.S
TiO2 Thr334 lacI 1436.3126 1436.6661 −0.3534 0 89 7.90×10−8 K.TTLAPNpTQTASPR.A
TiO2 Thr328/Thr329 lacI 1880.3242 1880.7948 −0.4705 2 74 2.20×10−7 K.RKpTpTLAPNpTQTASPR.A
TiO2 Ser345 lacI 1267.2794 1267.5995 −0.3201 0 78 8.20×10−7 R.ALADpSLMQLAR.Q
TiO2 Thr144 rpsA 991.1918 991.4376 −0.2457 0 24 0.026 R.DpTLHLEGK.E
TiO2 Ser169 rpsA 866.1780 866.4011 −0.2231 0 35 0.0096 R.NNVVVpSR.R
TiO2 Thr455/Thr459 rpsA 1488.3286 1488.6990 −0.3704 1 98 4.00×10−9 K.GAIVpTGKVpTAVDAK.G
P-bodies Thr2/Ser4 rpsA 1818.2380 1818.7188 −0.4807 0 45 1.10×10−4 -.MpTEpSFAQLFEESLK.E
TiO2 Ser73 rpsI 1122.2354 1122.5183 −0.2828 0 106 6.90×10−9 K.GGGIpSGQAGAIR.H
IMAC Ser128 rpsI 997.2474 997.4858 −0.2384 1 19 0.15 R.RRPQFpSK.R
TiO2 Thr20/Ser21 rpsM 1587.3568 1587.7463 −0.3894 0 95 8.00×10−9 K.HAVIALpTpSIYGVGK.T
TiO2 Ser74/Ser76 rpsM 1278.2396 1278.5556 −0.316 2 46 0.0013 R.REIpSMpSIKR.L
TiO2 Ser22/Thr24 rpsE 1486.3968 1486.7673 −0.3705 2 42 0.00069 K.LIAVNRVpSKpTVK.G
IMAC Thr20 rpsB 1188.2416 1188.5190 −0.2773 0 67 9.70×10−6 K.AGVHFGHQpTR.Y
TiO2 Ser95/Thr96 rpsK 1285.1976 1285.5217 −0.3241 1 36 0.0043 K.GPGPGREpSpTIR.A
P-bodies Thr3/Thr10 rplM 1695.3088 1695.782 −0.4732 2 58 2.50×10−5 -.MKpTFTAKPEpTVKR.D
TiO2 Thr3/Thr5/Thr10 rplM 1775.2999 1775.7483 −0.4485 2 79 3.40×10−7 -.MKpTFpTAKPEpTVKR.D
TiO2 Thr5/Ser12 rplO 1403.2528 1403.6098 −0.3570 1 43 0.00054 R.LNpTLSPAEGpSKK.A
TiO2 Ser25/Thr30 rplO 1218.2586 1218.5159 −0.2573 1 5 1.1 R.GIGpSGLGKpTGGR.G
TiO2 Ser73 rplE 687.1339 687.2993 −0.1654 0 33 0.046 K.pSVAGFK.I
TiO2 Thr63/Thr69 rplA 1224.2044 1224.5054 −0.3009 0 25 0.0069 R.GApTVLPHGpTGR.S
TiO2 Thr51/Thr52 rplC 1175.2374 1175.5352 −0.2978 1 20 0.013 R.AIQVpTpTGAKK.A
IMAC Ser19/Thr25 rpmB 1156.2116 1156.4791 −0.2674 1 64 3.90×10−5 R.pSHALNApTKR.R
IMAC Thr14/Ser19/Thr25 rpmB 2130.4324 2130.9238 −0.4914 2 62 2.00×10−6 K.RPVpTGNNRpSHALNApTKR.R
IMAC Ser30/Thr37/Thr39 rplV 1960.4137 1960.8713 −0.4576 2 51 0.00023 K.KVpSQALDILpTYpTNKK.A
TiO2 Thr60/Thr65 dnaK 1703.3538 1703.7685 −0.4146 0 38 0.00088 R.QAVpTNPQNpTLFAIK.R
TiO2 Ser453 dnaK 1677.3844 1677.7876 −0.4031 0 88 1.50×10−7 K.pSLGQFNLDGINPAPR.G
TiO2 Ser505 dnaK 1369.2368 1369.5762 −0.3394 0 67 1.10×10−6 K.ASpSGLNEDEIQK.M
TiO2 Ser201 gapA 1480.3204 1480.6923 −0.3718 0 65 4.30×10−6 R.GApSQNIIPSSTGAAK.A
TiO2 Ser201/Ser207 gapA 1560.2696 1560.6586 −0.3889 0 39 0.00055 R.GApSQNIIPpSSTGAAK.A
P-bodies Ser201/Thr209 gapA 1560.2372 1560.6586 −0.4213 0 38 0.0011 R.GApSQNIIPSSpTGAAK.A
TiO2 Ser239/Thr244 gapA 1654.3610 1654.7733 −0.4122 0 119 1.20×10−10 R.VPTPNVpSVVDLpTVR.L
IMAC Ser190 gapA 1376.2531 1376.5874 −0.3344 1 77 2.80×10−7 K.TVDGPpSHKDWR.G
TiO2 Thr544/Thr552 rpoD 1454.2760 1454.6320 −0.3559 0 62 2.10×10−6 R.AApTHDVLAGLpTAR.E
TiO2 Ser602/Ser604 rpoD 1239.2252 1239.5162 −0.2910 1 29 0.0058 R.HPpSRpSEVLR.S
TiO2 Thr67/Thr74 ihfA 1570.2908 1570.6793 −0.3885 1 103 5.00×10−10 R.NPKpTGEDIPIpTAR.R
TiO2 Thr66 ihfB 1154.2326 1154.5220 −0.2894 1 60 5.60×10−5 K.pTGDKVELEGK.Y
TiO2 Ser72 tig 1212.2142 1212.5210 −0.3067 0 90 2.90×10−7 R.QDVLGDLMpSR.N
TiO2 Ser9 crr 1211.3148 1211.6162 −0.3014 2 65 1.00×10−5 K.LKpSLVSDDKK.D
TiO2 Ser9/Ser12 crr 1291.2638 1291.5826 −0.3187 2 51 0.00038 K.LKpSLVpSDDKK.D
TiO2 Ser2/Thr6 cspA 1079.1738 1079.4487 −0.2749 1 43 0.0017 M.pSGKMpTGIVK.W
TiO2 Thr324/Thr327 ftsZ 1329.2768 1329.6095 −0.3326 0 67 1.60×10−6 K.RPEIpTLVpTNK.Q
TiO2 Thr71/Thr78 tatA 1991.2990 1991.7986 −0.4997 2 60 8.70×10−5 K.QADpTNQEQAKpTEDAKR.H
TiO2 Ser54/Thr60 infB 1387.2484 1387.5898 −0.3413 1 54 0.0001 K.NpSGPDKLpTLQR.K
TiO2 Ser9/Thr14 accD 1188.2380 1188.5305 −0.2924 1 52 0.00042 R.IKpSNITPpTR.K
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Table S1 Continued
Source Site Name Mr(expt) Mr(calc) Delta MC Score Expect Peptide
TiO2 Thr3 gatZ 911.2322 911.4663 −0.2341 1 46 0.0025 -.MKpTLIAR.H
TiO2 Ser476 aspA 1106.1322 1106.3917 −0.2595 1 45 0.0017 K.RYTDEpSEQ.-
TiO2 Thr626/Thr630 pnp 1082.1788 1082.4563 −0.2774 1 36 0.0098 R.VYpTGKVpTR.I
TiO2 Ser3/Thr8 gatD 1592.2680 1592.6671 −0.3990 1 41 0.00036 -.MKpSVVNDpTDGIVR.V
TiO2 Thr87/Thr97 sucB 1878.3088 1878.7761 −0.4673 2 40 0.0014 K.EpTSAKSEEKASpTPAQR.Q
TiO2 Ser75 frr 927.1428 927.3773 −0.2344 0 39 0.0078 R.SMpSPAVEK.A
TiO2 Ser2 lipA 1038.2284 1038.4933 −0.2648 0 30 0.019 M.pSKPIVMER.G
IMAC Thr6 yqjD 1316.2666 1316.5874 −0.3208 1 54 5.00×10−5 M.SKEHpTTEHLR.A
IMAC Thr7 yqjD 1316.2684 1316.5874 −0.3190 1 33 0.0047 M.SKEHTpTEHLR.A
IMAC Thr6/Thr7 yqjD 1396.2338 1396.5537 −0.3199 1 67 5.80×10−6 M.SKEHpTpTEHLR.A
IMAC Thr17 espF 921.2758 921.4069 −0.1311 0 29 0.026 R.HIpTSAASR.V
IMAC Thr76 grpE 1238.3146 1238.6020 −0.2873 2 28 0.039 R.RRpTELDIEK.A
IMAC Thr94 tufA 2736.8350 2737.2639 −0.4289 0 25 0.024 K.NMIpTGAAGMDGAILVVAATDGPMPQTR.E
P-bodies Thr176/Ser180 ahpC 1658.2694 1658.7205 −0.4511 0 35 0.0025 K.EGEApTLAPpSLDLVGK.I
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